Clinical significance of serum procalcitonin in patients with ulcerative colitis

被引:22
作者
Koido, Shigeo [1 ]
Ohkusa, Toshifumi [1 ]
Takakura, Kazuki [1 ]
Odahara, Shunichi [1 ]
Tsukinaga, Shintaro [1 ]
Yukawa, Toyokazu [1 ]
Mitobe, Jimi [1 ]
Kajihara, Mikio [1 ]
Uchiyama, Kan [1 ]
Arakawa, Hiroshi [1 ]
Tajiri, Hisao [1 ]
机构
[1] Jikei Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med, Kashiwa, Chiba 2778567, Japan
关键词
C-reactive protein; Disease activity; Procalcitonin; Severity; Ulcerative colitis; INFLAMMATORY-BOWEL-DISEASE; C-REACTIVE PROTEIN; BACTERIAL-INFECTION; CROHNS-DISEASE; SEPSIS; HYDROCORTISONE; THERAPY; MARKERS;
D O I
10.3748/wjg.v19.i45.8335
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the association of procalcitonin (PCT) with ulcerative colitis (UC) activity. METHODS: Serum PCT levels, C-reactive protein (CRP) levels, the erythrocyte sedimentation rate, and the white blood cell count were analyzed in 18 patients with UC and 11 healthy volunteers. Serum PCT levels were analyzed by an electrochemiluminescence immunoassay. Severity assessments were based on Truelove and Witts' severity index. Correlation of serum PCT and CRP levels with UC activity was examined. Moreover, we assessed serum PCT and CRP levels in patients with a Mayo endoscopic subscore. RESULTS: Serum PCT levels in severe UC patients (n = 7) (0.096 +/- 0.034 ng/mL) were significantly higher than in mild-to-moderate UC patients (n = 11) (0.033 +/- 0.012 ng/mL) and healthy volunteers (n = 11) (0.035 +/- 0.005 ng/mL) (P = 0.0005 and P < 0.0001, respectively). In addition, there was no difference in serum PCT levels between mild-to-moderate UC patients and healthy volunteers. Interestingly, patients with a Mayo endoscopic subscore of 3 points displayed significantly increased levels of serum PCT (0.075 +/- 0.043 ng/mL) compared with patients with a subscore of 2 points (0.03 +/- 0.011 ng/mL) (P = 0.0302). Moreover, CRP levels in patients with severe UC or a Mayo endoscopic subscore of 3 points were not significantly higher than in patients with mild-to-moderate UC or a Mayo endoscopic subscore of 3 points. CONCLUSION: Serum PCT levels were significantly correlated with UC activity. (C) 2013 Baishideng Publishing Group Co., Limited. All rights reserved.
引用
收藏
页码:8335 / 8341
页数:7
相关论文
共 28 条
[1]   Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target [J].
Becker, Kenneth L. ;
Snider, Richard ;
Nylen, Eric S. .
BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (02) :253-264
[2]   Evolving diagnostic strategies for inflammatory bowel disease [J].
Bruining D.H. ;
Loftus Jr. E.V. .
Current Gastroenterology Reports, 2006, 8 (6) :478-485
[3]   Hydrocortisone infusion for severe community-acquired pneumonia - A preliminary randomized study [J].
Confalonieri, M ;
Urbino, R ;
Potena, A ;
Piattella, M ;
Parigi, P ;
Puccio, G ;
Della Porta, R ;
Giorgio, C ;
Blasi, F ;
Umberger, R ;
Meduri, GU .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (03) :242-248
[4]   A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis [J].
D'Haens, Geert ;
Sandborn, William J. ;
Feagan, Brian G. ;
Geboes, Karel ;
Hanauer, Stephen B. ;
Irvine, E. Jan ;
Lemann, Marc ;
Marteau, Philippe ;
Rutgeerts, Paul ;
Scholmerich, Jurgen ;
Sutherland, Lloyd R. .
GASTROENTEROLOGY, 2007, 132 (02) :763-786
[5]   The influence of corticosteroids on the release of novel biomarkers in human endotoxemia [J].
de Kruif, Martijn D. ;
Lemaire, Lucienne C. ;
Giebelen, Ida A. ;
Struck, Joachim ;
Morgenthaler, Nils G. ;
Papassotiriou, Jana ;
Elliott, Peter J. ;
van der Poll, Tom .
INTENSIVE CARE MEDICINE, 2008, 34 (03) :518-522
[6]  
Eberhard OK, 1997, ARTHRITIS RHEUM, V40, P1250, DOI 10.1002/1529-0131(199707)40:7<1250::AID-ART9>3.0.CO
[7]  
2-A
[8]   Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis [J].
Herrlinger, KR ;
Dittmann, R ;
Weitz, G ;
Wehkamp, J ;
Ludwig, D ;
Schwab, M ;
Stange, EF ;
Fellermann, K .
INFLAMMATORY BOWEL DISEASES, 2004, 10 (03) :229-233
[9]   THE COMPLETE SEQUENCE OF HUMAN PREPROCALCITONIN [J].
LEMOULLEC, JM ;
JULLIENNE, A ;
CHENAIS, J ;
LASMOLES, F ;
GULIANA, JM ;
MILHAUD, G ;
MOUKHTAR, MS .
FEBS LETTERS, 1984, 167 (01) :93-97
[10]   Exogenous procalcitonin evokes a pro-inflammatory cytokine response [J].
Liappis, Angelike P. ;
Gibbs, Kevin W. ;
Nylen, Eric S. ;
Yoon, Bona ;
Snider, Richard H. ;
Gao, Baochong ;
Becker, Kenneth L. .
INFLAMMATION RESEARCH, 2011, 60 (02) :203-207